first large study of glp-1 receptor agonists during pregnancy agonist exposure linked to complications GLP-1s are everywhere, and so
Description
Nutr Metab Cardiovasc Dis
LIV Body identifies itself as the platform (LivBody HoldCo LLC, 317 6th Avenue, Suite 400, Des Moines, Iowa 50309)
Here is what caught researchers off guard: liraglutide, dulaglutide, and exenatide showed no statistically significant increase in hair loss reports at all

[DOI] [PubMed] [Google Scholar] 43.Cai X., et al

Sinha et al
Novo Nordisk) then took the market by storm when it followed with even superior efficacy
